Funder
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference18 articles.
1. Schmeisser, F., Vodeiko, G. M., Lugovtsev, V. Y., Stout, R. R. & Weir, J. P. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Vaccine 28, 2442–2449 (2010).
2. Li, C. et al. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals 38, 284–289 (2010).
3. Vodeiko, G. M. & Weir, J. P. Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza. Influenza Other Respir. Virus 6, 176–187 (2012).
4. World Health Organization. WHO Guidelines on the use of vaccines and antivirals during influenza pandemics: WHO/CDS/CSR/RMD/2004.8.
http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_RMD_2004_8/en/index.html
(2004)
5. Minor, P. D. Assaying the potency of influenza vaccines. Vaccines 3, 90–104 (2015).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献